We partner with other service leaders to provide you with end-to-end solutions for the development of biologics and ATMPs. Find out more about our strategic partnerships and how they strengthen our position as the collaborative, consultative and creative immunology CRO.
A leading product development and regulatory consulting practice serving the pharmaceutical and biotechnology industry.
Scendea are committed problem solvers, redefining the meaning of customer service, with a focus on reducing time-to-market and minimising development costs.
Scendea was founded as a result of a management buyout of the product development and regulatory consulting function of a clinical research organisation. Our origin dates back over 20 years, with involvement in over 1,000 development programmes. Our international team offers strategic and operational support in the fields of quality/CMC, non-clinical/toxicology, clinical/medical and regulatory, which guide products efficiently from early development to marketing approval.
Our scientific excellence, industry experience, commercial awareness and a collaborative approach allow our expert team to solve complex issues associated with medicinal product development. Scendea has team members based in the UK, Ireland, the Netherlands and the US, who deliver innovative and high-quality solutions aligned to jurisdiction-specific regulatory requirements.
At Scendea we collaborate, innovate, and together with our clients, we succeed. You can visit www.scendea.com to learn more.